Addict Behav

1. SCHWEBEL FJ, Wilson AD, Pearson MR, McCool MW, et al
   Finding purpose: Integrated latent profile and machine learning analyses identify purpose in life as an important predictor of high-functioning recovery after alcohol treatment.
   Addict Behav. 2025;165:108273.
   

   >> Share

   
   
2. JI X, Feng N, Zhao T, Cui L, et al
   Protective and risk factors in problematic mobile phone use among adolescents: A three-wave longitude study.
   Addict Behav. 2025;165:108299.
   

   >> Share

   
   

   
   Am J Epidemiol

3. HILLCOAT A, Jeon ED, Shrestha M, Jha SC, et al
   Detecting risk for depression and anxiety symptoms among older bereaved women using text-based analysis in the Nurses' Health Study II.
   Am J Epidemiol. 2025 Mar 13:kwaf056. doi: 10.1093.
   

   >> Share

   
   

   
   Behav Brain Res

4. LI R, Zhang Y, Zhang H, Wang C, et al
   CRMP2 in the hippocampus alleviates chronic stress-induced depressive-like behaviours in mice by affecting synaptic function.
   Behav Brain Res. 2025;484:115495.
   

   >> Share

   
   
5. KHATSKO SL, Zhdanov AV, Kravchenko DV, Nikiforova EV, et al
   The light-dark forced swim test for simultaneous assessment of behavioral 'despair' and anxiety-like behavior in female mice.
   Behav Brain Res. 2025;484:115492.
   

   >> Share

   
   

   
   Biol Psychiatry

6. REPPLE J, Bayas M, Moser C, Kobayashi NF, et al
   Current evidence for the role of rapid-acting antidepressants (RAAD) in bipolar depression? A perspective and plan for action.
   Biol Psychiatry. 2025 Mar 8:S0006-3223(25)01019.
   

   >> Share

   
   

   
   BMC Neurol

7. XIAO A, Wang R, Liu C, Wang X, et al
   Influencing factors and predictive models of early post-stroke depression in patients with acute ischemic stroke.
   BMC Neurol. 2025;25:104.
   

   >> Share

   
   

   
   Can J Psychiatry

8. OSTINELLI EG, Jaquiery M, Liu Q, Elgarf R, et al
   Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and big Data: The PETRUSHKA Tool: Personnalisation du traitement antidepresseur de la depression unipolaire associant choix individuels, risques et mega
   Can J Psychiatry. 2025 Mar 13:7067437251322399. doi: 10.1177/07067437251322399.
   

   >> Share

   
   

   
   J Pers

9. NORCINI PALA A, Turan B
   A Bayesian network analysis to examine the effects of HIV stigma processes on self-concept and depressive symptoms among persons living with HIV.
   J Pers. 2025;93:296-309.
   

   >> Share

   
   

   
   Neurologia (Engl Ed)

10. GOMEZ-EGUILAZ M, Lopez-Alava S, Ramon-Trapero JL, Castillo-Alvarez F, et al
    Focusing on post-COVID syndrome fatigue.
    Neurologia (Engl Ed). 2025;40:204-215.
    

    >> Share

    
    

    
    Pharmacol Biochem Behav

11. BABII Y, Palucha-Poniewiera A, Golembiowska K, Bysiek A, et al
    Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior.
    Pharmacol Biochem Behav. 2025 Mar 6:173996. doi: 10.1016/j.pbb.2025.173996.
    

    >> Share

    
    
12. YANG XY, Wang HQ, Meng-Zhang, Chen AP, et al
    Astrocyte gap junction dysfunction activates JAK2-STAT3 pathway to mediate inflammation in depression.
    Pharmacol Biochem Behav. 2025 Mar 5:173987. doi: 10.1016/j.pbb.2025.173987.
    

    >> Share

    
    

    
    PLoS One

13. ZHAO H, Xu M, Han Y, Liu S, et al
    Association between the ratio of serum uric acid to high density lipoprotein cholesterol and depressive symptoms in middle-aged and elderly Chinese.
    PLoS One. 2025;20:e0319465.
    

    >> Share

    
    

    
    Soc Psychiatry Psychiatr Epidemiol

14. CAVANAGH D, Hart LM, Basden S, Lu S, et al
    Prevalence estimates of depression and anxiety symptoms among adolescents in Bermuda, according to age, gender and race.
    Soc Psychiatry Psychiatr Epidemiol. 2025 Mar 11. doi: 10.1007/s00127-025-02829.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share